✦ LIBER ✦

Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor

✍ Scribed by Christina Papadaki; Annika Dufour; Marlene Seibl; Stephanie Schneider; Stefan K. Bohlander; Evelyn Zellmeier; Gudrun Mellert; Wolfgang Hiddemann; Karsten Spiekermann

Book ID: 108676097
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 267 KB
Volume: 144
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07488.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical implications of minimal residua

Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations

✍ Chou, W-C; Tang, J-L; Wu, S-J; Tsay, W; Yao, M; Huang, S-Y; Huang, K-C; Chen, C- 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

A novel quantitative assessment of minim

A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations

✍ Dvorakova, D; Lengerova, M; Pospisilova, J; Palasek, I; Mayer, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 178 KB

Monitoring of minimal residual disease (

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

✍ Viehmann, S; Teigler-Schlegel, A; Bruch, J; Langebrake, C; Reinhardt, D; Harbott 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB